Is photopatch testing useful in the investigation of photosensitivity due to flutamide?

Suppr

超能文献

作者信息

Martín-Lázaro J, Buján J Goday, Arrondo A Parra, Lozano J Rodríguez, Galindo E Cuerda, Capdevila E Fonseca

机构信息

Department of Allergy, Juan Canalejo Hospital, La Coruna, Spain.

出版信息

Contact Dermatitis. 2004 May;50(5):325-6. doi: 10.1111/j.0105-1873.2004.00341m.x.

DOI:10.1111/j.0105-1873.2004.00341m.x

PMID:15209825

Abstract

摘要

相似文献

Is photopatch testing useful in the investigation of photosensitivity due to flutamide?

Contact Dermatitis. 2004 May;50(5):325-6. doi: 10.1111/j.0105-1873.2004.00341m.x.

Flutamide photosensitivity--residual vitiliginous lesions.

Contact Dermatitis. 1998 Feb;38(2):68-70. doi: 10.1111/j.1600-0536.1998.tb05655.x.

Photosensitive drug eruption induced by flutamide.

Eur J Dermatol. 1998 Sep;8(6):427-9.

Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.

Eur J Dermatol. 2012 May-Jun;22(3):402-3. doi: 10.1684/ejd.2012.1719.

Celecoxib-induced photoallergic drug eruption.

Int J Dermatol. 2004 Jun;43(6):459-61. doi: 10.1111/j.1365-4632.2004.02149.x.

Evaluation of photopatch test series in India.

Contact Dermatitis. 2007 Mar;56(3):168-9. doi: 10.1111/j.1600-0536.2007.00974.x.

Flutamide-induced photoleukomelanoderma.

J Dermatol. 2016 Sep;43(9):1105-6. doi: 10.1111/1346-8138.13340. Epub 2016 Mar 11.

Photosensitivity induced by quinidine sulfate: experimental reproduction of skin lesions.

Photodermatol Photoimmunol Photomed. 1992 Apr;9(2):78-82.

Photoallergic contact dermatitis to Heracleum giganteum.

Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):99-101. doi: 10.1111/j.1600-0781.2008.00346.x.

[Flutamide and pseudoporphyria].

Ann Dermatol Venereol. 1999 Apr;126(4):374.

引用本文的文献

Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management.

Drug Saf. 2019 Jul;42(7):827-847. doi: 10.1007/s40264-019-00806-5.

Drug-induced photosensitivity: culprit drugs, management and prevention.

Drug Saf. 2011 Oct 1;34(10):821-37. doi: 10.2165/11592780-000000000-00000.

Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.

Drug Saf. 2007;30(8):645-55. doi: 10.2165/00002018-200730080-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Is photopatch testing useful in the investigation of photosensitivity due to flutamide?

Contact Dermatitis. 2004 May;50(5):325-6. doi: 10.1111/j.0105-1873.2004.00341m.x.

Flutamide photosensitivity--residual vitiliginous lesions.

Contact Dermatitis. 1998 Feb;38(2):68-70. doi: 10.1111/j.1600-0536.1998.tb05655.x.

Photosensitive drug eruption induced by flutamide.

Eur J Dermatol. 1998 Sep;8(6):427-9.

Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.

Eur J Dermatol. 2012 May-Jun;22(3):402-3. doi: 10.1684/ejd.2012.1719.

Celecoxib-induced photoallergic drug eruption.

Int J Dermatol. 2004 Jun;43(6):459-61. doi: 10.1111/j.1365-4632.2004.02149.x.

Evaluation of photopatch test series in India.

Contact Dermatitis. 2007 Mar;56(3):168-9. doi: 10.1111/j.1600-0536.2007.00974.x.

Flutamide-induced photoleukomelanoderma.

J Dermatol. 2016 Sep;43(9):1105-6. doi: 10.1111/1346-8138.13340. Epub 2016 Mar 11.

Photosensitivity induced by quinidine sulfate: experimental reproduction of skin lesions.

Photodermatol Photoimmunol Photomed. 1992 Apr;9(2):78-82.

Photoallergic contact dermatitis to Heracleum giganteum.

Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):99-101. doi: 10.1111/j.1600-0781.2008.00346.x.

[Flutamide and pseudoporphyria].

Ann Dermatol Venereol. 1999 Apr;126(4):374.

引用本文的文献

Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management.

Drug Saf. 2019 Jul;42(7):827-847. doi: 10.1007/s40264-019-00806-5.

Drug-induced photosensitivity: culprit drugs, management and prevention.

Drug Saf. 2011 Oct 1;34(10):821-37. doi: 10.2165/11592780-000000000-00000.

Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.

Drug Saf. 2007;30(8):645-55. doi: 10.2165/00002018-200730080-00001.